{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:59:13Z","timestamp":1775084353286,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["10.54499\/UIDB\/04585\/2020"],"award-info":[{"award-number":["10.54499\/UIDB\/04585\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chlorhexidine Gluconate (CHG) bathing is widely used in Intensive Care Units (ICUs) to reduce bacterial colonisation, yet its efficacy against fungal skin colonisation, particularly <jats:italic>Candida<\/jats:italic> spp., is not well understood. This study aimed to evaluate the impact of daily CHG bathing on <jats:italic>Candida<\/jats:italic> colonisation among ICU patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From 2020 to 2022, axillary\/inguinal swabs were collected from 675 ICU patients across three units on admission (Day 1, D1), Day 5 (D5) and Day 8 (D8). Patients received daily CHG bathing (either 2% impregnated wipes or 4% liquid solution) from D1 to D5, followed by soap-and-water bathing from Day 6 to D8. Standard and molecular microbiological methods were used to identify fungal species, and colony-forming units (CFUs) were quantified. Colonisation rates and fungal burden were compared across time points and bathing protocols.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 988 swabs from 675 patients were collected, 675 on D1, 203 on D5 and 110 on D8. CHG bathing had no significant impact on <jats:italic>Candida<\/jats:italic> burden at individual time points, (D1, <jats:italic>p<\/jats:italic>\u2009=\u20090.223; D5, <jats:italic>p<\/jats:italic>\u2009=\u20090.939 and D8, <jats:italic>p<\/jats:italic>\u2009=\u20090.669). No significant differences in colonisation or fungal burden were observed between the use of 4% CHG solution and 2% CHG-impregnated wipes upon ICU admission. However, in the subgroup of 89 patients monitored longitudinally, a transient reduction in colonisation was observed during the CHG bathing period (D1\u2013D5), followed by a significant increase during the soap-and-water period (D6\u2013D8) (<jats:italic>p<\/jats:italic>\u2009=\u20090.005; between periods: <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Among the 329 positive swabs, 274 yielded\u2009&gt;\u2009100 CFU\/ml. High colony counts of <jats:italic>C. albicans<\/jats:italic> (&gt;\u20091000 CFU\/mL) were observed, with no significant association between colonisation levels and specific <jats:italic>Candida<\/jats:italic> species (<jats:italic>p<\/jats:italic>\u2009=\u20090.940).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CHG bathing demonstrated only a limited and transient impact on <jats:italic>Candida<\/jats:italic> colonisation in ICU patients. Colonisation rates rebounded after cessation of CHG use, suggesting ongoing acquisition during ICU stay. These findings highlight the need for additional or alternative infection control measures targeting fungal pathogens in critical care settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13756-025-01606-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:50:25Z","timestamp":1752137425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can chlorhexidine gluconate baths reduce fungal colonisation in intensive care unit patients?"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7695-8686","authenticated-orcid":false,"given":"Teresa","family":"Nascimento","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7367-5007","authenticated-orcid":false,"given":"Jo\u00e3o","family":"In\u00e1cio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7181-4028","authenticated-orcid":false,"given":"Daniela","family":"Guerreiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3025-0628","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Patr\u00edcio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-5936","authenticated-orcid":false,"given":"Lu\u00eds","family":"Proen\u00e7a","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-6065","authenticated-orcid":false,"given":"Cristina","family":"Toscano","sequence":"additional","affiliation":[]},{"given":"Priscila","family":"Diaz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-5433","authenticated-orcid":false,"given":"Helena","family":"Barroso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"1606_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","volume":"161","author":"DO Thomas-R\u00fcddel","year":"2022","unstructured":"Thomas-R\u00fcddel DO, Schlattmann P, Pletz M, Kurzai O, Bloos F. Risk factors for invasive Candida infection in critically ill patients: A systematic review and Meta-analysis. Chest. 2022;161:345\u201355.","journal-title":"Chest"},{"key":"1606_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","volume":"30","author":"W Fang","year":"2023","unstructured":"Fang W, Wu J, Cheng M, Zhu X, Du M, Chen C, Liao W, Zhi K, Pan W. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30:42.","journal-title":"J Biomed Sci"},{"key":"1606_CR3","doi-asserted-by":"publisher","first-page":"106183","DOI":"10.1016\/j.jinf.2024.106183","volume":"89","author":"X Yang","year":"2024","unstructured":"Yang X, Li X, Qiu S, Liu C, Chen S, Xia H, Zeng Y, Shi L, Chen J, Zheng J, et al. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data. J Infect. 2024;89:106183.","journal-title":"J Infect"},{"key":"1606_CR4","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/jac\/dkad139","volume":"78","author":"A Soriano","year":"2023","unstructured":"Soriano A, Honore PM, Puerta-Alcalde P, Garcia-Vidal C, Pagotto A, Gon\u00e7alves-Bradley DC, Verweij PE. Invasive candidiasis: current clinical challenges and unmet needs in adult populations. J Antimicrob Chemother. 2023;78:1569\u201385.","journal-title":"J Antimicrob Chemother"},{"key":"1606_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl C, Kanj SS, Govender NP, Thompson GR, Ostrosky-Zeichner L, Govrins MA. Invasive candidiasis. Nat Rev Dis Primers. 2024;10:20.","journal-title":"Nat Rev Dis Primers"},{"key":"1606_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4040\/jkan.21046","volume":"51","author":"J Seo","year":"2021","unstructured":"Seo J, Song R. [Effect of 2% chlorhexidine bathing on the incidence of Hospital-Acquired infection and Multidrug-Resistant organisms in adult intensive care unit patients: systematic review and Meta-Analysis]. J Korean Acad Nurs. 2021;51:414\u201329.","journal-title":"J Korean Acad Nurs"},{"key":"1606_CR7","doi-asserted-by":"crossref","unstructured":"Schinas G, Polyzou E, Spernovasilis N, Gogos C, Dimopoulos G, Akinosoglou K. Preventing Multidrug-Resistant bacterial transmission in the intensive care unit with a comprehensive approach: A policymaking manual. Antibiot (Basel) 2023, 12.","DOI":"10.3390\/antibiotics12081255"},{"key":"1606_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jhin.2019.08.025","volume":"103","author":"SS Huang","year":"2019","unstructured":"Huang SS. Chlorhexidine-based decolonization to reduce healthcare-associated infections and multidrug-resistant organisms (MDROs): who, what, where, when, and why? J Hosp Infect. 2019;103:235\u201343.","journal-title":"J Hosp Infect"},{"key":"1606_CR9","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.ajic.2017.02.038","volume":"45","author":"JS Musuuza","year":"2017","unstructured":"Musuuza JS, Sethi AK, Roberts TJ, Safdar N. Implementation of daily chlorhexidine bathing to reduce colonization by multidrug-resistant organisms in a critical care unit. Am J Infect Control. 2017;45:1014\u20137.","journal-title":"Am J Infect Control"},{"key":"1606_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ajic.2024.01.019","volume":"52","author":"EAC Peixoto","year":"2024","unstructured":"Peixoto EAC, Poveda VB, Gnatta JR, Oliveira RA. Bathing with wipes impregnated with chlorhexidine gluconate to prevent central line-associated bloodstream infection in critically ill patients: A systematic review with meta-analysis. Am J Infect Control. 2024;52:731\u20138.","journal-title":"Am J Infect Control"},{"key":"1606_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41591-021-01383-w","volume":"27","author":"DM Proctor","year":"2021","unstructured":"Proctor DM, Dangana T, Sexton DJ, Fukuda C, Yelin RD, Stanley M, Bell PB, Baskaran S, Deming C, Chen Q, et al. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med. 2021;27:1401\u20139.","journal-title":"Nat Med"},{"key":"1606_CR12","doi-asserted-by":"crossref","unstructured":"Johnson CJ, Eix EF, Lam BC, Wartman KM, Meudt JJ, Shanmuganayagam D, Nett JE. Augmenting the activity of chlorhexidine for decolonization of Candida auris from Porcine skin. J Fungi (Basel) 2021, 7.","DOI":"10.3390\/jof7100804"},{"key":"1606_CR13","doi-asserted-by":"crossref","unstructured":"Rhee Y, Simms AT, Schoeny M, Baker AW, Baker MA, Gohil S, Rhee C, Talati NJ, Warren DK, Welbel S et al. Relationship between chlorhexidine gluconate concentration and microbial colonization of patients\u2019 skin. Infect Control Hosp Epidemiol 2024:1\u20136.","DOI":"10.1017\/ice.2024.81"},{"key":"1606_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/jhin.2000.0897","volume":"47","author":"I Palabiyiko\u011flu","year":"2001","unstructured":"Palabiyiko\u011flu I, Oral M, Tulunay M. Candida colonization in mechanically ventilated patients. J Hosp Infect. 2001;47:239\u201342.","journal-title":"J Hosp Infect"},{"key":"1606_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/1369378031000147458","volume":"41","author":"S Ahmad","year":"2003","unstructured":"Ahmad S, Khan Z, Mustafa AS, Khan ZU. Epidemiology of Candida colonization in an intensive care unit of a teaching hospital in Kuwait. Med Mycol. 2003;41:487\u201393.","journal-title":"Med Mycol"},{"key":"1606_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00134-005-2571-y","volume":"31","author":"PE Charles","year":"2005","unstructured":"Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B. Candida spp. Colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31:393\u2013400.","journal-title":"Intensive Care Med"},{"key":"1606_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","volume":"379","author":"DW Eyre","year":"2018","unstructured":"Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018;379:1322\u201331.","journal-title":"N Engl J Med"},{"key":"1606_CR18","first-page":"100937","volume":"82","author":"V Avkan-O\u011fuz","year":"2022","unstructured":"Avkan-O\u011fuz V, \u00c7el\u0130k M, Eren-Kutsoylu O, Nazli A, U\u011fur YL, Taylan A, Ergan B, Irmak \u00c7, Du\u011fral E, \u00d6zk\u00fct\u00fck AA. Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital. Respir Med Res. 2022;82:100937.","journal-title":"Respir Med Res"},{"key":"1606_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s42770-022-00715-3","volume":"53","author":"HK Sarvestani","year":"2022","unstructured":"Sarvestani HK, Ramandi A, Getso MI, Razavyoon T, Javidnia J, Golrizi MB, Saboor-Yaraghi AA, Ansari S. Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology. Braz J Microbiol. 2022;53:689\u2013707.","journal-title":"Braz J Microbiol"},{"key":"1606_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mimet.2015.02.004","volume":"111","author":"G Criseo","year":"2015","unstructured":"Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods. 2015;111:50\u20136.","journal-title":"J Microbiol Methods"},{"key":"1606_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1128\/JCM.43.1.284-292.2005","volume":"43","author":"A Tavanti","year":"2005","unstructured":"Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. Nov. To replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43:284\u201392.","journal-title":"J Clin Microbiol"},{"key":"1606_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mimet.2009.07.016","volume":"79","author":"O Romeo","year":"2009","unstructured":"Romeo O, Scordino F, Pernice I, Lo Passo C, Criseo G. A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis. J Microbiol Methods. 2009;79:117\u201320.","journal-title":"J Microbiol Methods"},{"key":"1606_CR23","doi-asserted-by":"crossref","unstructured":"Arastehfar A, Fang W, Pan W, Liao W, Yan L, Boekhout T. Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR. BMC Infect Dis 2018, 18:480.","DOI":"10.1186\/s12879-018-3381-5"},{"key":"1606_CR24","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1128\/JCM.00630-17","volume":"55","author":"M Kordalewska","year":"2017","unstructured":"Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging Multidrug-Resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445\u201352.","journal-title":"J Clin Microbiol"},{"key":"1606_CR25","doi-asserted-by":"crossref","unstructured":"Nascimento T, In\u00e1cio J, Guerreiro D, Patr\u00edcio P, Proen\u00e7a L, Toscano C, Diaz P, Barroso H. Insights into Candida colonization in intensive care unit patients: A prospective multicenter study. J Fungi (Basel) 2024, 10.","DOI":"10.3390\/jof10060378"},{"key":"1606_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijid.2020.10.092","volume":"102","author":"H Alenazy","year":"2021","unstructured":"Alenazy H, Alghamdi A, Pinto R, Daneman N. Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: A systematic review and meta-analysis. Int J Infect Dis. 2021;102:357\u201362.","journal-title":"Int J Infect Dis"},{"key":"1606_CR27","first-page":"CD012248","volume":"8","author":"SR Lewis","year":"2019","unstructured":"Lewis SR, Schofield-Robinson OJ, Rhodes S, Smith AF. Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection. Cochrane Database Syst Rev. 2019;8:CD012248.","journal-title":"Cochrane Database Syst Rev"},{"key":"1606_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cmi.2018.09.012","volume":"25","author":"C Pallotto","year":"2019","unstructured":"Pallotto C, Fiorio M, De Angelis V, Ripoli A, Franciosini E, Quondam Girolamo L, Volpi F, Iorio P, Francisci D, Tascini C, Baldelli F. Daily bathing with 4% chlorhexidine gluconate in intensive care settings: a randomized controlled trial. Clin Microbiol Infect. 2019;25:705\u201310.","journal-title":"Clin Microbiol Infect"},{"key":"1606_CR29","doi-asserted-by":"crossref","unstructured":"Esarte J, Mujika A. [Chlorhexidine bathing in intensive care units for the prevention of nosocomial infections. A systematic review]. Sist Sanit Navar 2022, 45.","DOI":"10.23938\/ASSN.1027"},{"key":"1606_CR30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1086\/667371","volume":"33","author":"KJ Popovich","year":"2012","unstructured":"Popovich KJ, Lyles R, Hayes R, Hota B, Trick W, Weinstein RA, Hayden MK. Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate. Infect Control Hosp Epidemiol. 2012;33:889\u201396.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1606_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1389203720666190722152415","volume":"21","author":"M Staniszewska","year":"2020","unstructured":"Staniszewska M. Virulence factors in Candida species. Curr Protein Pept Sci. 2020;21:313\u201323.","journal-title":"Curr Protein Pept Sci"},{"key":"1606_CR32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/ice.2023.177","volume":"44","author":"Y Rhee","year":"2023","unstructured":"Rhee Y, Hayden MK, Schoeny M, Baker AW, Baker MA, Gohil S, Rhee C, Talati NJ, Warren DK, Welbel S, et al. Impact of measurement and feedback on chlorhexidine gluconate bathing among intensive care unit patients: A multicenter study. Infect Control Hosp Epidemiol. 2023;44:1375\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1606_CR33","doi-asserted-by":"publisher","first-page":"101666","DOI":"10.1016\/j.bjid.2021.101666","volume":"26","author":"MAO Reis","year":"2022","unstructured":"Reis MAO, de Almeida MCS, Escudero D, Medeiros EA. Chlorhexidine gluconate bathing of adult patients in intensive care units in S\u00e3o paulo, brazil: impact on the incidence of healthcare-associated infection. Braz J Infect Dis. 2022;26:101666.","journal-title":"Braz J Infect Dis"},{"key":"1606_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jdent.2012.04.003","volume":"40","author":"AR Fathilah","year":"2012","unstructured":"Fathilah AR, Himratul-Aznita WH, Fatheen AR, Suriani KR. The antifungal properties of chlorhexidine digluconate and cetylpyrinidinium chloride on oral Candida. J Dent. 2012;40:609\u201315.","journal-title":"J Dent"},{"key":"1606_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/myc.12699","volume":"60","author":"A Abdolrasouli","year":"2017","unstructured":"Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017;60:758\u201363.","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"1606_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.medin.2018.09.010","volume":"43","author":"E D\u00edaz","year":"2019","unstructured":"D\u00edaz E, Tur\u00e9gano C. Daily skin antisepsis and hygiene in the critically ill patient. Med Intensiva (Engl Ed). 2019;43(Suppl 1):13\u20137.","journal-title":"Med Intensiva (Engl Ed)"},{"key":"1606_CR37","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1038\/s41467-022-32249-5","volume":"13","author":"NAR Gow","year":"2022","unstructured":"Gow NAR, Johnson C, Berman J, Coste AT, Cuomo CA, Perlin DS, Bicanic T, Harrison TS, Wiederhold N, Bromley M, et al. The importance of antimicrobial resistance in medical mycology. Nat Commun. 2022;13:5352.","journal-title":"Nat Commun"},{"key":"1606_CR38","doi-asserted-by":"publisher","first-page":"100403","DOI":"10.1016\/j.infpip.2024.100403","volume":"6","author":"T Nascimento","year":"2024","unstructured":"Nascimento T, In\u00e1cio J, Guerreiro D, Diaz P, Patr\u00edcio P, Proen\u00e7a L, Toscano C, Barroso H. Susceptibility patterns of Candida species collected from intensive care units in portugal: a prospective study in 2020\u20132022. Infect Prev Pract. 2024;6:100403.","journal-title":"Infect Prev Pract"},{"key":"1606_CR39","doi-asserted-by":"publisher","first-page":"102381","DOI":"10.1016\/j.mib.2023.102381","volume":"76","author":"M Tuor","year":"2023","unstructured":"Tuor M, LeibundGut-Landmann S. The skin mycobiome and intermicrobial interactions in the cutaneous niche. Curr Opin Microbiol. 2023;76:102381.","journal-title":"Curr Opin Microbiol"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01606-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T03:35:50Z","timestamp":1757216150000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01606-6","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Hospital Prof. Doutor Fernando Fonseca (59\/2019, 13\/11\/2019) and the Institutional Ethics Committee of Hospital Beatriz \u00c2ngelo (3655\/2021, 21\/07\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}],"article-number":"87"}}